Physician profile
Brent Earls
NPI 1104280957
$7,201.61
in general payments reported to CMS, 2019-2025
25 companies · $53.14 in 2025
The $53.14 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,271 · 2021: $657 · 2022: $681 · 2023: $1,841 · 2024: $699 · 2025: $53.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111 · Travel and Lodging: $448 · Education: $34.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.55 |
| Travel and Lodging | $447.80 |
| Education | $34.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,020.33 | 2020 | |
| Abbott Laboratories | $1,281.10 | 2021-2024 | Proclaim, Eterna, Octrode |
| Nevro Corp. | $702.05 | 2020-2024 | Senza |
| Saluda Medical Americas, INC. | $447.80 | 2023 | Evoke Scs |
| Vertos Medical, INC. | $363.37 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $238.23 | 2020-2024 | Wavewriter Alpha Prime 16, Intracept |
| Curonix LLC | $200.84 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $176.19 | 2022-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Bioness INC | $171.16 | 2021 | |
| Alnylam Pharmaceuticals INC. | $161.15 | 2022-2024 | Givlaari |
| Scilex Pharmaceuticals INC. | $99.23 | 2022-2024 | Ztlido |
| Merck Sharp & Dohme LLC | $53.14 | 2025 | Bridion |
| Stimwave Technologies Incorporated | $36.41 | 2022 | |
| Bioventus LLC | $27.07 | 2021 | |
| Spr Therapeutics, INC | $26.58 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $25.25 | 2023 | Horizant |
| Biotronik Nro, INC. | $24.04 | 2024 | Prospera |
| Allergan, INC. | $22.96 | 2022 | |
| Lundbeck LLC | $22.40 | 2021 | |
| Abbvie INC. | $21.99 | 2022 | |
| Relievant Medsystems, INC. | $20.73 | 2023 | Intracept |
| Ibsa Pharma INC. | $18.40 | 2024 | Tirosint, Licart |
| Biohaven Pharmaceuticals, INC. | $17.13 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.34 | 2022 | |
| Foundation Fusion Solutions, LLC | $11.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Earls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.